💥MEI Pharma Adopts #Litecoin : A Milestone in Institutional Adoption

MEI Pharma has surprised the market by announcing a $100 million investment in Litecoin ($LTC ) for its main treasury. This bold move positions Litecoin at the heart of its financial strategy, marking a significant milestone in the institutional adoption of crypto assets.

Charlie Lee, founder of Litecoin, joins the board of MEI Pharma, further solidifying this strategic partnership. The market reaction has been immediate and positive, with MEI Pharma's shares soaring more than 50%. This decision by a publicly traded company in the U.S. underscores the growing confidence in Litecoin as a stable and accessible treasury asset, opening new doors for the integration of traditional finance and blockchain technology.